Quick Answer
Androgenetic alopecia cannot be permanently cured because inherited sensitivity to dihydrotestosterone (DHT) stays with hair roots for life. However, early medical treatment can partly reverse it and significantly slow it. Hair roots that have shrunk (miniaturised) can produce thicker hair again, whereas areas that have been completely bald for years rarely respond to medicine alone.
Androgenetic alopecia is the most prevalent form of hair fall in both men and women, commonly known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL). It is primarily driven by genetic factors combined with the activity of androgenic hormones on hair follicles. While stress, smoking, and nutritional deficiencies do not directly cause pattern hair fall, they can accelerate its progression.
The term "alopecia" is a general medical name for hair fall. Temporary types of fall, like Telogen Effluvium, settle once the underlying trigger is addressed. In contrast, androgenetic alopecia is a progressive, lifelong condition that requires continuous management.
How Does Androgenetic Alopecia Affect Hair Growth?
Androgenetic alopecia affects hair growth when dihydrotestosterone (DHT) binds to androgen receptors in genetically sensitive hair follicles. Over time, this shortens the hair growth phase and causes follicles to shrink, producing progressively thinner and shorter hair strands.
Normally, scalp hair follows these three main stages of growth:
- Growth phase (Anagen): Hair grows actively for approximately two to six years.
- Transition phase (Catagen): Hair growth stops, and the lower part of the follicle shrinks over two to three weeks.
- Resting phase (Telogen): Hair remains at rest for around two to three months before it is eventually shed.
In androgenetic alopecia, the enzyme 5-alpha reductase converts testosterone into DHT. Hair follicles that are genetically sensitive to DHT gradually become smaller through a process called follicular miniaturisation.
This progressively shortens the anagen phase, reducing the time available for hair growth. As the condition advances, affected follicles produce finer, shorter strands, leading to visible hair thinning around the hairline, crown or central scalp.

Can Androgenetic Alopecia Be Cured?
No, there is currently no permanent androgenetic alopecia cure. The condition is passed down through many genes from either or both parents. Treatments can reduce this effect, but they cannot change the genes behind it, so the tendency toward thinning remains.
Can Androgenetic Alopecia Be Reversed or Stopped?
Androgenetic alopecia can be partially reversed with treatment, but it cannot be permanently cured. Medicines such as minoxidil and finasteride can slow hair thinning and improve hair density in some people. However, continued treatment is usually necessary to maintain these improvements.
This happens because of follicular miniaturisation, a process in which hair follicles gradually shrink and produce finer, shorter strands. The active growth phase (anagen) also becomes shorter. If the affected follicles remain capable of producing hair, treatment may help them produce thicker strands again.
A clinical trial by Kaufman and colleagues involving 1,553 men aged 18–41 found that participants taking finasteride had approximately 138 more hairs than those taking a placebo within a measured scalp area after two years. A subsequent five-year study found that continued finasteride treatment helped maintain improvements and slow further thinning.
Early treatment generally offers a better chance of preserving existing hair, although the extent of recovery varies with the severity of thinning and individual response.
What Factors Determine How Much Hair Recovery Is Possible?
The extent of hair regrowth in androgenetic alopecia depends on the age at which treatment begins, the severity of thinning, the condition of the affected follicles and the scalp area involved.
A 2015 study by Yoshitake and colleagues involving 801 men treated with finasteride identified age and the severity of thinning as factors associated with treatment response.
The four factors that mainly influenced the results of hair recovery in the study was:
- Men who started finasteride treatment at age 40 or older generally showed a weaker response in the study.
- Mild to moderate thinning is generally more responsive than extensive baldness.
- Areas that still produce fine hair strands have greater potential for improvement than areas with little visible hair.
- Finasteride has stronger established evidence for improving hair density at the crown than at the frontal hairline.

Why Does the Stage of Androgenetic Alopecia Affect Treatment Results?
The stage of androgenetic alopecia affects treatment results because earlier stages have a higher number of active, miniaturised hair roots that can produce thick terminal hair again, whereas advanced stages feature fibrosed or inactive roots that respond poorly to medical therapy alone.
Dermatologists usually use two different classification systems to assess androgenetic alopecia in men and women. The Norwood-Hamilton scale describes male-pattern balding, while the Ludwig scale measures female-pattern hair thinning.
The sections below show what treatment can usually achieve at each stage:
Androgenetic Alopecia Stages and Treatment Results in Men
Medical outcomes vary significantly based on the progression of follicular miniaturisation across the Norwood and Ludwig scales.
The Norwood-Hamilton scale classifies male-pattern balding based on hairline recession and thinning across the crown:
|
Stage |
What It Looks Like |
Potential Treatment Results |
|
Early (Norwood 1–3) |
Minimal to noticeable temple recession, sometimes with early crown thinning |
Treatment may help maintain hair density and improve thickness in areas with active follicles. |
|
Moderate (Norwood 4–5) |
Significant hairline recession and crown thinning, with a band of hair separating the areas |
Medicines may improve density in thinning regions, although deeply receded areas are less responsive. |
|
Advanced (Norwood 6–7) |
Extensive baldness across the frontal and crown regions, with limited hair remaining on top |
Medicines may help preserve remaining hair. Hair transplantation may be considered if sufficient donor hair is available. |
Androgenetic Alopecia Stages and Treatment Results in Women
The Ludwig scale classifies female-pattern hair thinning according to the reduction in hair density across the top of the scalp:
|
Stage |
What It Looks Like |
Potential Treatment Results |
|
Early (Ludwig I) |
Mild thinning around the central parting, with the frontal hairline usually preserved |
Treatment may help improve hair density and reduce further thinning. |
|
Moderate (Ludwig II) |
Noticeable widening of the central parting and reduced hair density across the crown |
Treatment may improve thickness in responsive areas, although complete density recovery is less likely. |
|
Advanced (Ludwig III) |
Thinning across the top of the scalp, with significant scalp visibility |
Medicines may improve remaining hair density, but recovery is often limited. Hair transplantation may be considered in selected patients with suitable donor hair. |
Note: These scales describe the visible extent of androgenetic alopecia, but they cannot predict treatment success on their own. Follicle activity, duration of thinning and individual response also influence the results.
How Can You Slow Down Androgenetic Alopecia?
Androgenetic alopecia can be slowed with clinically supported treatments that help maintain hair density and reduce progressive thinning. A dermatologist can recommend suitable medicines or procedures based on the pattern of thinning, medical history and individual treatment needs.
Clinical interventions work through distinct mechanisms - ranging from inhibiting enzymes to stimulating tissue - to protect existing hair roots and improve hair coverage across the scalp:
|
Treatment |
How It Helps |
Strength of Evidence |
|
Topical Minoxidil |
Helps stimulate hair growth and maintain hair density. Available as scalp solutions and foams for men and women. |
Strong evidence from clinical trials |
|
Oral Finasteride |
Reduces DHT production, helping slow genetic hair thinning in eligible men. |
Strong evidence from long-term clinical trials |
|
Topical Finasteride |
Reduces DHT activity in the scalp, with generally lower systemic exposure than oral finasteride. |
Promising evidence, with fewer long-term studies |
|
Low-Level Light Therapy |
Uses specific wavelengths of light to stimulate follicle activity and potentially improve hair density. |
Moderate evidence, with results varying by device and treatment protocol |
|
Platelet-Rich Plasma (PRP) |
Uses concentrated platelets from the patient's blood, injected into the scalp to support hair growth. |
Promising but inconsistent evidence due to differences in treatment protocols |
|
Hair Transplantation |
Relocates healthy follicles from donor areas to regions affected by thinning. |
Established surgical treatment for suitable candidates |
Important: Finasteride requires medical supervision and may cause sexual or mood-related side effects. Topical finasteride can also enter the bloodstream and cause systemic effects. Minoxidil may cause scalp irritation and temporary increased hair fall during the initial weeks. Treatment should be selected after discussing the potential benefits, limitations and risks with a dermatologist.
Can Female Androgenetic Alopecia Be Reversed?
Yes, partly. Women usually notice thinning over the top of the head and a wider center parting, while the front hairline stays mostly intact and complete baldness is rare.
Topical minoxidil is the main approved treatment for women. Finasteride is avoided in women who are pregnant or may become pregnant, because it can harm a developing baby.
Women are often tested for low iron, thyroid problems, and polycystic ovary syndrome (PCOS). Correcting these can reduce extra hair fall, but it does not change the answer to whether alopecia can be cured because of the inherited pattern itself.
Does Androgenetic Alopecia Stop on Its Own?
No, it does not stop on its own, although its speed varies and thinning may seem to pause for a while.
A 2008 analysis, published in the European Journal of Dermatology, tracked men who took only a placebo for five years. They lost about 26% of their hair density in the measured area, and 75% looked visibly thinner by the end.
The condition also becomes more common with age, affecting about half of Caucasian men by 50 and around 80% by 70. A quiet year is therefore not proof that alopecia can be cured, because the process usually continues in the background.
What Happens When Treatment Stops?
When treatment stops, the hair gained or kept through it is gradually lost over the following months. Hair then returns to roughly the state it would have reached if treatment had never been used.
Hair transplants move DHT-resistant roots from the back of the head into thinning areas, where they usually last. However, the original hair around them can keep thinning, so a transplant is not a complete, permanent treatment for androgenetic alopecia on its own.
Traya's Perspective on Androgenetic Alopecia Reversal
Androgenetic alopecia requires consistent, long-term care to slow thinning and preserve existing hair density. There could be several reasons why androgenetic alopecia sets in - along with genetics, it could be hormonal imbalances or nutritional deficiencies as well, which need to be identified with a root-cause approach.
Traya follows a personalized 3-Science approach that combines Hair Science, Ayurveda, and Nutrition to address the root causes of hair fall. Depending on the assessment, the plan may include nutritional support, scalp care and doctor-recommended treatments where appropriate.
Early treatment can improve the chances of hair recovery, particularly when affected follicles are still active. Identifying the underlying causes and choosing the right treatment are key to managing the condition effectively.
A Traya Free Hair Test can help you assess your hair concerns and guide treatment recommendations.
Frequently Asked Questions
Can hair grow back from androgenetic alopecia?
Yes, hair can grow back in areas where follicles are still active but produce thin, weak strands. Treatments such as minoxidil and finasteride may help improve hair thickness and density. However, androgenetic alopecia cannot be permanently cured, and areas that have remained completely bald for several years are less likely to respond to medicines alone.
Can I reverse androgenetic alopecia naturally?
No natural remedy has been proven to reverse androgenetic alopecia. Some ingredients, such as saw palmetto, have shown potential benefits in small clinical studies because they may reduce DHT activity. However, the available evidence is insufficient to establish their effectiveness as reliable treatments.
Natural remedies should not replace established medicines such as minoxidil or finasteride. Consult a dermatologist before taking herbal supplements, particularly if you are using other medicines.
Is stage 4 balding reversible?
Stage 4 balding on the Norwood scale may show partial improvement with treatment, depending on the condition of the remaining hair follicles. At this stage, the temples have receded considerably, and thinning is usually visible at the crown, with a band of hair separating the two areas.
Medicines may improve hair density in areas where fine strands remain, particularly around the crown. Deeply receded temples are generally less responsive. Dermatologists typically assess treatment progress over 6–12 months using scalp examinations and comparison photographs.
References
-
International Society of Hair Restoration Surgery (ISHRS). (2024). Androgenetic Alopecia: A Guide to Pattern Hair Loss. ISHRS.
-
International Society of Hair Restoration Surgery (ISHRS). (2024). Telogen Effluvium: A Guide to Temporary Hair Loss. ISHRS.
-
Ho CH, Sood T, Zito PM. (2024). Androgenetic Alopecia. StatPearls, NCBI Bookshelf.
-
Kanti V, Messenger A, Dobos G, et al. (2018). Evidence-based (S3) Guideline for the Treatment of Androgenetic Alopecia in Women and in Men, Short Version. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.14624
-
Kaufman KD, Olsen EA, et al. (1998). Finasteride in the Treatment of Men With Androgenetic Alopecia. Journal of the American Academy of Dermatology. DOI: 10.1016/S0190-9622(98)70007-6
-
The Finasteride Male Pattern Hair Loss Study Group. (2002). Long-term (5-year) Multinational Experience With Finasteride 1 mg in the Treatment of Men With Androgenetic Alopecia. European Journal of Dermatology.
-
Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J. (2008). Progression of Hair Loss in Men With Androgenetic Alopecia (Male Pattern Hair Loss): Long-term (5-year) Controlled Observational Data in Placebo-treated Patients. European Journal of Dermatology.
-
Yoshitake T, Takeda A, Ohki K, et al. (2015). Five-year Efficacy of Finasteride in 801 Japanese Men With Androgenetic Alopecia. The Journal of Dermatology. DOI: 10.1111/1346-8138.12890
-
Suchonwanit P, Thammarucha S, Leerunyakul K. (2019). Minoxidil and Its Use in Hair Disorders: A Review. Drug Design, Development and Therapy. DOI: 10.2147/DDDT.S214907
- Evron E, Juhasz M, Babadjouni A, Mesinkovska NA. (2020). Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia. Skin Appendage Disorders. DOI: 10.1159/000509905





























